Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Return on Sales (2022 - 2025)

Cardio Diagnostics Holdings' Return on Sales history spans 4 years, with the latest figure at 600.54% for Q3 2025.

  • For Q3 2025, Return on Sales fell 38586.0% year-over-year to 600.54%; the TTM value through Sep 2025 reached 415.16%, down 18391.0%, while the annual FY2024 figure was 240.28%, 25060.0% up from the prior year.
  • Return on Sales for Q3 2025 was 600.54% at Cardio Diagnostics Holdings, down from 225.18% in the prior quarter.
  • Across five years, Return on Sales topped out at 163.66% in Q2 2024 and bottomed at 4263.58% in Q1 2023.
  • The 4-year median for Return on Sales is 299.15% (2023), against an average of 1091.23%.
  • The largest annual shift saw Return on Sales skyrocketed 400218bps in 2024 before it crashed -147803bps in 2025.
  • A 4-year view of Return on Sales shows it stood at 2503.22% in 2022, then surged by 90bps to 261.57% in 2023, then decreased by -29bps to 336.73% in 2024, then plummeted by -78bps to 600.54% in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Return on Sales are 600.54% (Q3 2025), 225.18% (Q2 2025), and 1739.43% (Q1 2025).